Acumen Pharmaceuticals CEO Daniel O'Connell's 2023 pay jumps 48% to $3.9M
Acumen Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 22, 2024
Acumen Pharmaceuticals reported fiscal year 2023 executive compensation information on April 22, 2024.
In 2023, three executives at Acumen Pharmaceuticals received on average a compensation package of $2.3M, a 37% increase compared to previous year.
Average pay of disclosed executives at Acumen Pharmaceuticals
Daniel O'Connell, Chief Executive Officer, received $3.9M in total, which increased by 48% compared to 2022. 56% of O'Connell's compensation, or $2.2M, was in option awards. O'Connell also received $427K in non-equity incentive plan, $598K in salary, $697K in stock awards, as well as $18K in other compensation.
Matthew Zuga, Chief Financial Officer, received a compensation package of $1.6M, which increased by 35% compared to previous year. 44% of the compensation package, or $699K, was in option awards.
Derek Meisner, Chief Legal Officer, earned $1.5M in 2023, a 15% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2024.